back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-11-05 11:52 Tx date 2019-11-01 |
$DMA
DiaMedica Therapeutics Inc. |
Gilman, Sydney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2019-11-05 11:28 Tx date 2019-11-01 |
$DMA
DiaMedica Therapeutics Inc. |
Gilman, Sydney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-19 15:18 Tx date 2019-08-16 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,365
+7,260 vol $2.67 each |
8,260 | |
| Filed 2019-08-19 15:16 Tx date 2019-08-16 |
$DMA
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,676
+1,000 vol $2.68 each |
467,100 | |
| Filed 2019-08-19 15:14 Tx date 2019-08-19 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,290
+3,000 vol $2.43 each |
89,850 | |
| Filed 2019-08-19 15:12 Tx date 2019-08-16 |
$DMA
DiaMedica Therapeutics Inc. |
Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,039
+7,840 vol $2.56 each |
233,090 | |
| Filed 2019-06-27 12:02 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+99,750 vol |
1,104,750 | |
| Filed 2019-06-27 12:00 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
625,000 | |
| Filed 2019-06-27 11:59 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+71,025 vol |
1,650,525 | |
| Filed 2019-06-27 11:58 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+264,000 vol |
4,584,000 | |
| Filed 2019-06-27 11:56 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Xiao, Zhenyu
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,950 vol |
172,950 | |
| Filed 2019-06-27 11:54 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,950 vol |
512,950 | |
| Filed 2019-06-27 11:52 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,700 vol |
1,193,700 | |
| Filed 2019-06-27 11:51 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,950 vol |
637,950 | |
| Filed 2019-05-31 16:32 Tx date 2019-05-31 |
$DMA
DiaMedica Therapeutics Inc. |
Pilnik, Richard D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,200
+19,000 vol $2.80 each |
225,250 | |
| Filed 2019-05-30 13:21 Tx date 2019-05-24 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,770
+4,000 vol $2.94 each |
86,850 | |
| Filed 2018-12-11 Tx date 2015-10-23 |
$DMA
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
Xiao, Zhenyu
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+3,250 vol |
3,250 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+11,250 vol |
741,214 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+1,000 vol |
21,000 |